Which bottleneck should we recode?
Start from a causal failure mode rather than an unconstrained engineering wish list.

Mechanistic maps become most powerful when they change what a therapeutic cell can do. We build receptors and intracellular programs that recode suppressive environments.
Enter the program ↓Can a cue that normally disables a T cell become the signal that sustains its survival and function?
Our engineering is grounded in systems-level evidence: identify the bottleneck, establish causality, then design the smallest intervention that changes therapeutic behavior without erasing useful biology.
Start from a causal failure mode rather than an unconstrained engineering wish list.
Quantify how tissue cues alter signaling, metabolism, proteostasis, and cell state.
Establish the smallest molecular intervention capable of changing therapeutic behavior.
Build receptors and intracellular programs that preserve adaptation while redirecting fate.
Link each strategy to peer-reviewed mechanism and preclinical functional evidence.
The study engineers fusion proteins that pair TGF-β-receptor extracellular domains with IL-2-receptor signaling domains, then tests whether a suppressive environmental cue can instead support activation, proliferation, and function in engineered T cells.
Engineer proteostasis, metabolic, and epigenetic programs that resist exhaustion while preserving adaptive capacity.
Design synthetic receptors that transform hostile tumor cues into survival or activation programs.
Integrate measurement and modeling toward digital physiological twins that make cell behavior more programmable.
Each connection is curated to show how published evidence informs the questions, methods, or engineering logic of this research program.